Company Valuation: Thermo Fisher Scientific, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 184,605 262,925 216,998 205,083 198,988 215,010 - -
Change - 42.43% -17.47% -5.49% -2.97% 8.05% - -
Enterprise Value (EV) 1 196,015 293,318 242,962 231,923 226,254 243,296 238,972 233,174
Change - 49.64% -17.17% -4.54% -2.44% 7.53% -1.78% -2.43%
P/E ratio 29.2x 34.3x 31.2x 34.4x 31.5x 32.1x 28.9x 25.2x
PBR 5.39x 6.45x 4.89x 4.39x 4x 4.12x 3.78x 3.46x
PEG - 1.6x -3.32x -2.8x 4.51x 4.02x 2.6x 1.7x
Capitalization / Revenue 5.73x 6.71x 4.83x 4.79x 4.64x 4.86x 4.62x 4.38x
EV / Revenue 6.08x 7.48x 5.41x 5.41x 5.28x 5.5x 5.14x 4.75x
EV / EBITDA 19.2x 22.6x 20.3x 21.3x 20.8x 21.8x 19.9x 18.3x
EV / EBIT 20.5x 24.2x 22.1x 23.6x 23.3x 24.1x 22x 19.9x
EV / FCF 28.8x 41.8x 35x 33.5x 30.9x 36.8x 27.8x 24.9x
FCF Yield 3.48% 2.39% 2.85% 2.99% 3.24% 2.72% 3.59% 4.02%
Dividend per Share 2 0.88 1.04 1.2 1.4 1.56 1.649 1.719 1.805
Rate of return 0.19% 0.16% 0.22% 0.26% 0.3% 0.29% 0.3% 0.32%
EPS 2 15.96 19.46 17.63 15.45 16.53 17.85 19.8 22.73
Distribution rate 5.51% 5.34% 6.81% 9.06% 9.44% 9.24% 8.68% 7.94%
Net sales 1 32,218 39,211 44,915 42,857 42,879 44,261 46,519 49,111
EBITDA 1 10,214 12,969 11,971 10,878 10,863 11,169 12,001 12,713
EBIT 1 9,556 12,138 10,985 9,810 9,707 10,083 10,839 11,702
Net income 1 6,375 7,725 6,950 5,995 6,335 6,707 7,384 8,280
Net Debt 1 11,410 30,393 25,964 26,840 27,266 28,286 23,962 18,164
Reference price 2 465.78 667.24 550.69 530.79 520.23 572.28 572.28 572.28
Nbr of stocks (in thousands) 396,335 394,048 394,048 386,372 382,500 375,708 - -
Announcement Date 2/1/21 2/2/22 2/1/23 1/31/24 1/30/25 - - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
32.06x5.5x21.78x0.29% 215B
71.91x18.86x44.03x-.--% 192B
43.51x7.07x22.82x0.55% 160B
44.83x7.28x23.75x-.--% 137B
20.73x2.48x12.06x2.31% 57.67B
36.61x7.45x24.66x-.--% 48.21B
31.31x5.95x21.21x0.7% 39.54B
18.34x2.11x11.92x0.15% 38.25B
24.05x6.34x16.41x0.96% 36.77B
25.25x6.46x18.44x2.64% 34.25B
Average 34.86x 6.95x 21.71x 0.76% 95.91B
Weighted average by Cap. 42.20x 8.56x 25.52x 0.46%
See all sector valuations

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. TMO Stock
  4. Valuation Thermo Fisher Scientific, Inc.